Most cited papers from Mount Sinai Medical Center
What are the most cited papers from Mount Sinai Medical Center?
The most cited paper from Mount Sinai Medical Center is "Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation" (Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al., 2011), with 9,484 citations. Next come "Quantification of coronary artery calcium using ultrafast computed tomography" (7,833) and "Edoxaban versus Warfarin in Patients with Atrial Fibrillation" (5,195).
Showing 50 of 60 papers. Every paper with more than 1,078 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine | 10 Aug 2011 | 9,484 |
| 2 | Quantification of coronary artery calcium using ultrafast computed tomography Arthur S. Agatston, Warren R. Janowitz, Frank J. Hildner et al. · Journal of the American College of Cardiology | Mar 1990 | 7,833 |
| 3 | Edoxaban versus Warfarin in Patients with Atrial Fibrillation Robert Patrick Giugliano et al. · New England Journal of Medicine | 19 Nov 2013 | 5,195 |
| 4 | Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet | May 2002 | 4,190 |
| 5 | Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis Paul J. Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine | 7 Dec 2005 | 3,927 |
| 6 | Successful Aging John W. Rowe, Robert L. Kahn · The Gerontologist | Aug 1997 | 3,815 |
| 7 | Coronary Plaque Disruption Erling Falk, Prediman Krishan Shah, Valentı́n Fuster · Circulation | Aug 1995 | 3,539 |
| 8 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Brian W. Kunkle et al. · Nature Genetics | 28 Feb 2019 | 3,277 |
| 9 | Nursing Research: Principles and Methods Stephen R. Marrone · AORN Journal | Dec 1987 | 3,241 |
| 10 | Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine | 14 Apr 2010 | 3,137 |
| 11 | Heart Disease and Stroke Statistics—2009 Update WRITING GROUP MEMBERS et al. · Circulation | 16 Dec 2008 | 3,132 |
| 12 | The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure The Digitalis Investigation Group · New England Journal of Medicine | 20 Feb 1997 | 3,043 |
| 13 | Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis David H Adams et al. · New England Journal of Medicine | 29 Mar 2014 | 2,920 |
| 14 | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber et al. · Blood | 29 Jun 2022 | 2,906 |
| 15 | Mapping genomic loci implicates genes and synaptic biology in schizophrenia Vassily Vladimirovich Trubetskoy et al. · Nature | 8 Apr 2022 | 2,894 |
| 16 | Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine | 6 May 1999 | 2,765 |
| 17 | New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics | Apr 2022 | 2,608 |
| 18 | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease Christopher G. Goetz, Werner H Poewe, Olivier Rascol et al. · Movement Disorders | 16 Jun 2004 | 2,390 |
| 19 | Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology | 18 Apr 2007 | 2,283 |
| 20 | Consensus Statement of the Movement Disorder Society on Tremor Günther Deuschl, Peter G. Bain, Mitchell F. Brin · Movement Disorders | 20 Oct 2008 | 1,995 |
| 21 | Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention Parisa Karimi, Farhad Islami, Sharmila Anandasabapathy et al. · Cancer Epidemiology Biomarkers & Prevention | 11 Mar 2014 | 1,964 |
| 22 | Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction Michael O. Sweeney, Anne S. Hellkamp, Kenneth A. Ellenbogen et al. · Circulation | 4 Jun 2003 | 1,789 |
| 23 | Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma Noopur S Raje et al. · New England Journal of Medicine | May 2019 | 1,775 |
| 24 | Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee Asher A. Kornbluth, David B. Sachar · The American Journal of Gastroenterology | Jul 2004 | 1,765 |
| 25 | Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study Jesús G. Berdeja et al. · The Lancet | 24 Jun 2021 | 1,751 |
| 26 | Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature Ethan A. Halm, Clara Lee, Mark R. Chassin · Annals of Internal Medicine | 17 Sep 2002 | 1,717 |
| 27 | Spontaneous Intracerebral Hemorrhage Adnan Iqbal Qureshi, Stanley Tuhrim, Joseph P. Broderick et al. · New England Journal of Medicine | 10 May 2001 | 1,677 |
| 28 | Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors Hans D. Brightbill, Daniel H. Libraty, Stephan R. Krutzik et al. · Science | 30 Jul 1999 | 1,675 |
| 29 | American Cancer Society Guidelines for the Early Detection of Cancer Robert Allen Smith, Vilma E. Cokkinides, Andrew C. von Eschenbach et al. · CA A Cancer Journal for Clinicians | 2002 | 1,598 |
| 30 | Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI Charles Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine | 14 Nov 2016 | 1,595 |
| 31 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Wolfgang Hueber et al. · Gut | 17 May 2012 | 1,542 |
| 32 | The International Position on Laparoscopic Liver Surgery Joseph F. Buell et al. · Annals of Surgery | 29 Oct 2009 | 1,529 |
| 33 | Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients Charlotte Cunningham‐Rundles, Carol Bodian · Clinical Immunology | Jul 1999 | 1,525 |
| 34 | Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease Amit V. Khera, Connor A. Emdin, Isabel Drake et al. · New England Journal of Medicine | 13 Nov 2016 | 1,509 |
| 35 | Depression and Risk for Alzheimer Disease Raymond L. Ownby, Elizabeth Crocco, Amarilis Acevedo et al. · Archives of General Psychiatry | May 2006 | 1,497 |
| 36 | Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma Aleksandar Sekulić, Michael Robert Migden, Anthony E. Oro et al. · New England Journal of Medicine | 7 Jun 2012 | 1,464 |
| 37 | Angiographic progression of coronary artery disease and the development of myocardial infarction John A. Ambrose, Mark A. Tannenbaum, Dimitrios K. Alexopoulos et al. · Journal of the American College of Cardiology | Jul 1988 | 1,457 |
| 38 | Lung Function Testing: Selectionof reference Values and Interpretative Strategies Albert Miller · American Review of Respiratory Disease | Nov 1992 | 1,430 |
| 39 | ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE C. Warren Olanow, W. G. Tatton · Annual Review of Neuroscience | Mar 1999 | 1,401 |
| 40 | A method for assessing the quality of a randomized control trial Thomas C. Chalmers, Harry Smith, Bradley A. Blackburn et al. · Controlled Clinical Trials | May 1981 | 1,376 |
| 41 | Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors Pablo Rubinstein, Carmelita M. Carrier, Andromachi Scaradavou et al. · New England Journal of Medicine | 26 Nov 1998 | 1,333 |
| 42 | A Behavioral Perspective on Insomnia Treatment Arthur J. Spielman, Lauren S. Caruso, Paul B. Glovinsky · Psychiatric Clinics of North America | Dec 1987 | 1,263 |
| 43 | Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee Asher A. Kornbluth, David B. Sachar · The American Journal of Gastroenterology | 12 Jan 2010 | 1,245 |
| 44 | The Utility of Simulation in Medical Education: What Is the Evidence? Yasuharu Okuda, Ethan Oliver Bryson, Samuel DeMaria et al. · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine | 29 Jul 2009 | 1,225 |
| 45 | Intensive glucose control and macrovascular outcomes in type 2 diabetes Fiona Turnbull, Carlos Abraira, Robert J. Anderson et al. · Diabetologia | 4 Aug 2009 | 1,208 |
| 46 | A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. Hyun Chae Jung, Lars Eckmann, Shen K. Yang et al. · Journal of Clinical Investigation | 1995 | 1,205 |
| 47 | Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis Crystal Lee, Rachel Huxley, Rachel P. Wildman et al. · Journal of Clinical Epidemiology | 25 Mar 2008 | 1,205 |
| 48 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Jedd D. Wolchok, Bart Neyns, Gerald P. Linette et al. · The Lancet Oncology | 9 Dec 2009 | 1,198 |
| 49 | Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation James D. Douketis, Alex C. Spyropoulos, Scott Kaatz et al. · New England Journal of Medicine | 22 Jun 2015 | 1,186 |
| 50 | The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease Ekaterina A. Rogaeva et al. · Nature Genetics | 14 Jan 2007 | 1,182 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.